MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 70 filers reported holding MAGENTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $43,000 | -38.6% | 14,854 | -6.6% | 0.00% | – |
| Q4 2021 | $70,000 | -41.2% | 15,899 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $119,000 | -27.4% | 16,375 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $164,000 | +14.7% | 16,764 | +38.9% | 0.00% | 0.0% |
| Q1 2021 | $143,000 | +52.1% | 12,065 | +0.3% | 0.00% | – |
| Q4 2020 | $94,000 | +11.9% | 12,034 | -2.8% | 0.00% | – |
| Q3 2020 | $84,000 | +7.7% | 12,379 | +19.5% | 0.00% | – |
| Q2 2020 | $78,000 | +9.9% | 10,360 | -8.9% | 0.00% | – |
| Q1 2020 | $71,000 | -61.0% | 11,373 | -5.5% | 0.00% | -100.0% |
| Q4 2019 | $182,000 | +46.8% | 12,030 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $124,000 | -32.2% | 12,131 | -2.0% | 0.00% | 0.0% |
| Q2 2019 | $183,000 | +21.2% | 12,382 | +34.7% | 0.00% | 0.0% |
| Q1 2019 | $151,000 | +906.7% | 9,189 | +260.8% | 0.00% | – |
| Q4 2018 | $15,000 | -53.1% | 2,547 | -4.9% | 0.00% | – |
| Q3 2018 | $32,000 | – | 2,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $19,599,000 | 7.18% |
| TCG Crossover Management, LLC | 2,124,122 | $6,160,000 | 2.47% |
| Atlas Venture Life Science Advisors, LLC | 3,476,536 | $10,082,000 | 1.28% |
| Deep Track Capital, LP | 5,359,000 | $15,541,000 | 1.00% |
| GREAT POINT PARTNERS LLC | 1,170,000 | $3,393,000 | 0.82% |
| Casdin Capital, LLC | 2,773,468 | $8,043,000 | 0.36% |
| Alphabet Inc. | 3,339,138 | $9,684,000 | 0.31% |
| Bleichroeder LP | 484,400 | $1,405,000 | 0.25% |
| HARBOR CAPITAL ADVISORS, INC. | 151,599 | $440,000 | 0.21% |
| Integral Health Asset Management, LLC | 201,000 | $583,000 | 0.15% |